ATE171457T1 - Antivirale verbindungen - Google Patents

Antivirale verbindungen

Info

Publication number
ATE171457T1
ATE171457T1 AT94912709T AT94912709T ATE171457T1 AT E171457 T1 ATE171457 T1 AT E171457T1 AT 94912709 T AT94912709 T AT 94912709T AT 94912709 T AT94912709 T AT 94912709T AT E171457 T1 ATE171457 T1 AT E171457T1
Authority
AT
Austria
Prior art keywords
pct
nucleoside analog
mono
sec
formula
Prior art date
Application number
AT94912709T
Other languages
English (en)
Inventor
Bernt Borretzen
Are Dalen
Finn Myhren
Kjell Torgeir Stokke
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Application granted granted Critical
Publication of ATE171457T1 publication Critical patent/ATE171457T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
AT94912709T 1993-04-05 1994-04-05 Antivirale verbindungen ATE171457T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307043A GB9307043D0 (en) 1993-04-05 1993-04-05 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE171457T1 true ATE171457T1 (de) 1998-10-15

Family

ID=10733340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912709T ATE171457T1 (de) 1993-04-05 1994-04-05 Antivirale verbindungen

Country Status (20)

Country Link
US (1) US6153594A (de)
EP (1) EP0693077B1 (de)
JP (1) JP3049258B2 (de)
KR (1) KR100309194B1 (de)
AT (1) ATE171457T1 (de)
AU (1) AU685104B2 (de)
CA (1) CA2158853C (de)
CZ (1) CZ287755B6 (de)
DE (1) DE69413529T2 (de)
DK (1) DK0693077T3 (de)
ES (1) ES2124883T3 (de)
FI (1) FI111370B (de)
GB (1) GB9307043D0 (de)
HU (1) HU228064B1 (de)
NZ (1) NZ263888A (de)
PL (1) PL177263B1 (de)
RU (1) RU2139884C1 (de)
SK (1) SK281231B6 (de)
UA (1) UA41361C2 (de)
WO (1) WO1994022887A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515279D0 (en) * 1995-07-25 1995-09-20 Norsk Hydro As Improved therapeutic agents
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
DE69812934T2 (de) * 1997-01-24 2004-01-29 Conpharma As Oslo Gemcitabin-derivate
US5891881A (en) * 1997-11-21 1999-04-06 Clarion Pharmaceuticals Inc. Aminoheterocycle-substituted glycerols
AU1412299A (en) * 1997-11-25 1999-06-15 Protarga, Inc. Nucleoside analog compositions and uses thereof
EP1095947B1 (de) 1998-07-09 2007-03-14 Sankyo Company Limited Antibakterielle verbindungen
AU5475799A (en) * 1998-08-10 2000-03-06 Centre National De La Recherche Scientifique Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis
US6277830B1 (en) 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
AU762395B2 (en) * 1998-10-16 2003-06-26 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
US6403564B1 (en) 1998-10-16 2002-06-11 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
AU2001255495A1 (en) * 2000-04-20 2001-11-07 Schering Corporation Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rnain patients having chronic hepatitis c infection
PY0111577A (es) 2000-05-23 2017-01-02 Idenix Cayman Ltd Métodos y composiciones para el tratamiento del virus de la hepatitis c
BR0111196A (pt) 2000-05-26 2004-04-06 Idenix Cayman Ltd Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus
WO2003062388A2 (en) * 2002-01-16 2003-07-31 The Regents Of The University Of California Inhibition of rna function
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
AP2005003213A0 (en) 2002-06-28 2005-03-31 Univ Cagliari 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
US20040077607A1 (en) * 2002-10-21 2004-04-22 Uckun Fatih M. Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
CA2503890A1 (en) * 2002-11-01 2004-05-13 Evogenix Pty Ltd Mutagenesis methods using ribavirin and/or rna replicases
RU2005118421A (ru) 2002-11-15 2006-01-20 Айденикс (Кайман) Лимитед (Ky) 2'-разветвленные нуклеозиды и мутация flaviviridae
TWI332507B (en) 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
AU2003300901A1 (en) 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
EP1745573A4 (de) * 2003-03-20 2010-05-26 Microbiol Quimica Farmaceutica Verfahren zur herstellung von 2 -deoxy-beta-l-nukleosiden
KR20060092242A (ko) * 2003-11-03 2006-08-22 코그니스 아이피 매니지먼트 게엠베하 아실 리보뉴클레오시드 및 아실 데옥시리보뉴클레오시드
FR2874016B1 (fr) 2004-06-30 2006-11-24 Centre Nat Rech Scient Cnrse Nanoparticules de derives de la gemcitabine
US9029345B2 (en) * 2005-03-16 2015-05-12 Case Western Reserve University Selective inhibitors of translesion DNA replication
WO2006101911A1 (en) 2005-03-16 2006-09-28 Case Western Reserve University Selective inhibitors of translesion dna replication
NO324263B1 (no) * 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2009042766A1 (en) * 2007-09-26 2009-04-02 Mount Sinai School Of Medicine Azacytidine analogues and uses thereof
US9988680B2 (en) 2011-09-01 2018-06-05 Case Western Reserve University Non-natural nucleosides as theranostic agents
US9821173B2 (en) 2013-02-08 2017-11-21 Case Western Reserve University Anti-cancer agents and methods of use

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3A (en) * 1836-08-01 1836-08-11 Thomas Blanchard Machine for turning and wooden sheaves and pins for ships' tackle blocks and pulleys
GB1325798A (en) * 1970-09-24 1973-08-08 Upjohn Co Derivatives of 2,2-anhydro-ara-cytidine
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US3998807A (en) * 1972-03-03 1976-12-21 Syntex (U.S.A.) Inc. Arabinofuranosyl cytosines and methods of making
GB1482736A (en) * 1974-03-18 1977-08-10 Icn Pharmaceuticals 1-(beta-d-ribofuranosyl)-1,2,4-triazole acid derivatives
US3960836A (en) * 1974-07-22 1976-06-01 Eli Lilly And Company Acylated derivatives of pyrazofurin and process for their preparation
JPS5159880A (en) * 1974-11-22 1976-05-25 Asahi Chemical Ind N44 ashirunukureoshidojikarubonsanesuteruno seiho
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
JPH0655755B2 (ja) * 1985-01-23 1994-07-27 富山化学工業株式会社 新規な５−フルオロ−２′−デオキシウリジン−３′−ホスフエ−ト誘導体およびその塩
US4684631A (en) * 1984-10-09 1987-08-04 Toyama Chemical Co., Ltd. Novel 5-fluoro-2-deoxyuridine derivatives and salts thereof, process for producing the same, and antitumor agents containing the same
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
JPS6483092A (en) * 1987-09-24 1989-03-28 Arakawa Chotaro & Co Novel n6,n6-dimethyladenosine derivative having carcinostatic activity, its production and carcinostatic agent containing said derivative as active component
EP0355031A3 (de) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
JPH0278696A (ja) * 1988-09-13 1990-03-19 Shoichiro Ozaki ５−フルオロウラシル誘導体
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
EP0450102A4 (en) * 1989-10-26 1992-05-06 Yamasa Shoyu Kabushiki Kaisha Nucleoside derivative
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
RU2071773C1 (ru) * 1993-07-19 1997-01-20 Товарищество с ограниченной ответственностью "Полисан" Лекарственное средство для лечения синдромов приобретенного иммунодефицита, в том числе вич-обусловленных

Also Published As

Publication number Publication date
HUT73659A (en) 1996-09-30
UA41361C2 (uk) 2001-09-17
SK281231B6 (sk) 2001-01-18
AU685104B2 (en) 1998-01-15
JP3049258B2 (ja) 2000-06-05
DE69413529D1 (de) 1998-10-29
CA2158853A1 (en) 1994-10-13
HU228064B1 (en) 2012-09-28
ES2124883T3 (es) 1999-02-16
CZ259395A3 (en) 1996-06-12
PL310970A1 (en) 1996-01-22
NZ263888A (en) 1998-05-27
DE69413529T2 (de) 1999-04-29
AU6514194A (en) 1994-10-24
DK0693077T3 (da) 1999-06-14
PL177263B1 (pl) 1999-10-29
HK1003437A1 (en) 1998-10-30
HU9502896D0 (en) 1995-11-28
CA2158853C (en) 1999-07-27
FI111370B (fi) 2003-07-15
RU2139884C1 (ru) 1999-10-20
WO1994022887A1 (en) 1994-10-13
EP0693077A1 (de) 1996-01-24
FI954727L (fi) 1995-10-04
EP0693077B1 (de) 1998-09-23
CZ287755B6 (en) 2001-01-17
KR100309194B1 (ko) 2002-06-20
FI954727A0 (fi) 1995-10-04
GB9307043D0 (en) 1993-05-26
US6153594A (en) 2000-11-28
SK123395A3 (en) 1996-04-03
JPH08508477A (ja) 1996-09-10

Similar Documents

Publication Publication Date Title
ATE171457T1 (de) Antivirale verbindungen
ES2115665T3 (es) Derivado de triterpeno.
IT8219610A0 (it) Procedimento per minimizzare l'emissione di impurita' da impianti di combustione.
FI941085A0 (fi) O-heteroaryyli-, O-alkyyliheteroaryyli-, O-alkenyyliheteroaryyli- ja O-alkynyyliheteroaryylimakrolideja
HUP0001640A2 (hu) N6-helyzetben heterociklusosan szubsztituált adenozinszármazékok, alkalmazásuk gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
NO940804D0 (no) Imidazolidylmakrolider
TW347333B (en) Antiviral pharmaceutical and veterinary compositions
ES2056096T3 (es) Purinil-ciclobutanos.
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES2117976T3 (es) Preparacion de derivados n-acetil neuraminicos.
ES8401042A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
NO932287L (no) 2'-deosky-2',2'-difluor(2,6,8-substituerte)purin-nukleosider med antiviralog anticanceraktivitet, og mellomprodukter
JPS5791998A (en) Novel 5'-o-acylnucleoside derivative and its preparation
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
ES2013379A6 (es) Procedimiento para preparar 6-sulfenamido-6, sulfinamido- y 6-sulfonamido-purinas, nucleosidos de purinas y nucleotidos de purinas antitumorales.
ES8609482A1 (es) Un metodo para producir acido dihidrodesoxigriseolico y sa- les y esteres del mismo
ATE158297T1 (de) Halbsynthetische gangliosidanaloge
ES2111791T3 (es) Esteres de acidos grasos de derivados de metilglucosido.
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
DE69120670D1 (de) Lipo-oligosaccharide als pflanzenspezifisches regulierendes mittel, verfahren zu ihrer herstellung und ihre verwendungen
MX9301667A (es) Acidos 7-oxo-7h-pirido(1,2,3-de)(1,4)-benzoxacin-6-carboxilicos y sus esteres y medicamentos que los contienen.
IT1247510B (it) Composizioni terapeutiche ad attivita' anti-hiv costituite da 2',3'-didesossiadenosina e sostanze inibitrici della adenosina-deaminasi
ATE77837T1 (de) Verfahren zur herstellung von optisch aktiven bicyclo (3.3.0> octandioncarbonsaeureestern.
MY102247A (en) Phosphorylated acylglycosides, their preparation and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner